1.15

4.17% -0.05

After Hours: 1.16 0.01 +0.87%

Sunshine Biopharma Inc (SBFM)

Overview News Price History Financials Discussions Forecast Stock Split

Sunshine Biopharma Inc stock is traded at $1.15, with a volume of 101.97K. It is down -4.17% in the last 24 hours and down -40.10% over the past month. Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

Previous Close:

$1.20

Open:

$1.18

24h Volume:

101.97K

Relative Volume:

0.06

Market Cap:

$2.74M

Revenue:

$35.49M

Net Income/Loss:

$-6.04M

P/E Ratio:

-0.0883

EPS:

-13.0191

Net Cash Flow:

$-6.42M

1W Performance:

-6.50%

1M Performance:

-40.10%

6M Performance:

-90.17%

1Y Performance:

-92.38%

1-Day Range:

$1.14

$1.21

1-Week Range:

$1.14

$1.25

52-Week Range:

$1.10

$24.30

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Name

Sunshine Biopharma Inc

Sector

Healthcare (1080)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

954-330-0684

Address

333 LAS OLAS WAY, FORT LAUDERDALE

Employee

Twitter

Next Earnings Date

2026-08-11

Latest SEC Filings

SBFM's Discussions on Twitter

Compare SBFM vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SBFM Sunshine Biopharma Inc	1.15	2.88M	35.49M	-6.04M	-6.42M	-13.02
TAK Takeda Pharmaceutical Co Adr	17.63	55.60B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.77	42.81B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.70	43.16B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.79	30.39B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	499.73	21.95B	3.17B	1.29B	1.01B	27.09

Sunshine Biopharma Inc Stock (SBFM) Latest News

04:18 AM

L1 Capital (SBFM) discloses 4.99% Sunshine Biopharma stake plus large warrant position - Stock Titan

04:18 AM

Aug 13, 2026

Sunshine Biopharma (SBFM) investors cap warrant-driven stake at 9.99% - Stock Titan

Aug 13, 2026

Aug 11, 2026

Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market - The Lawton Constitution

Aug 11, 2026

Aug 09, 2026

SBFM Stock Holds Support As Traders Eye Next Move - timothysykes.com

Aug 09, 2026

Aug 08, 2026

SBFM Stock Holds Support As Sunshine Biopharma Tightens Cash Control - StocksToTrade

Aug 08, 2026

SBFM Stock Holds Range As Traders Weigh Weak Margins - timothysykes.com

Aug 08, 2026

Aug 07, 2026

SBFM Stock Slides As Traders Focus On Cash Runway And Volatility - StocksToTrade

Aug 07, 2026

Sunshine Biopharma receives Canadian approval for generic dienogest By Investing.com - Investing.com Nigeria

Aug 04, 2026

Sunshine Biopharma receives Canadian approval for generic dienogest - Investing.com

Aug 04, 2026

Sunshine Biopharma's 2mg Tablet for Endometriosis Pain Wins Canadian Approval - Stock Titan

Aug 04, 2026

EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval - Benzinga

Aug 04, 2026

SBFM Q2'26 Earnings: EPS estimate is (1.20) USD - TradingView

Aug 04, 2026

Sunshine Biopharma wins Canadian approval for generic Dienogest tablets - Bitget

Aug 04, 2026

Aug 03, 2026

Sunshine Biopharma cuts exercise price of outstanding Series B warrants to $1.22 - Bitget

Aug 03, 2026

Jul 29, 2026

SBFM Q2'26 Earnings: revenue estimate is 8.70M USD - TradingView

Jul 29, 2026

Jul 28, 2026

SBFM Looks 79.1% Undervalued on GF Value™ Amid Challenging Finan - GuruFocus

Jul 28, 2026

Sunshine Biopharma receives Canadian approval for ondansetron - Investing.com

Jul 28, 2026

Sunshine Biopharma receives Canadian approval for ondansetron By Investing.com - Investing.com Canada

Jul 28, 2026

Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting - New Castle News

Jul 28, 2026

Jul 27, 2026